Big Call Screening: Hannover Re, Novo Nordisk, Amgen, GEA

Heavyweights from the reinsurance sector have come under significant pressure recently following another disappointing contract renewal round. Given the ongoing impacts of climate change, prices in the property and casualty segment are expected to continue rising in the medium term, keeping the outlook for heavyweights like Hannover Re promising. The Danish pharmaceutical sector leader Novo Nordisk seems to have successfully moved past the crisis and can, particularly due to its newly approved obesity pill, make new strides in this multi-billion...